Prothena Corp Public (PRTA) Shares Outstanding (Weighted Average) (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Shares Outstanding (Weighted Average) of $53.7 million in Q1 2026, little changed quarter-over-quarter from $53.8 million in Q4 2025, and little changed on a YoY basis from $53.8 million in Q1 2025.

Prothena Corp Public (PRTA) Shares Outstanding (Weighted Average) (2012 - 2026) Analysis & Trends

Prothena Corp Public's Shares Outstanding (Weighted Average) history runs 15 years deep, the most recent figure standing at $53.7 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) changed 0.22% year-over-year to $53.7 million; the TTM figure through Mar 2026 stood at $53.7 million (changed 0.22% YoY), while the FY2025 annual figure was $53.8 million, changed 0.11% from the prior year.
  • Shares Outstanding (Weighted Average) was $53.7 million for Q1 2026 at Prothena Corp Public, roughly flat from $53.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $53.8 million in Q3 2025 to a low of $46.7 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $52.0 million across 5 years, with a median of $53.7 million in 2026.
  • The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) increased 16.03% in 2022, then dropped 0.22% in 2026.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $47.4 million in 2022, then rose by 12.34% to $53.2 million in 2023, then gained by 1.04% to $53.8 million in 2024, then grew by 0.11% to $53.8 million in 2025, then declined by 0.22% to $53.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $53.7 million (Q1 2026), $53.8 million (Q4 2025), and $53.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Prothena Corp Public 479.08 Mn 149.61 Mn - 53.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.71 Mn
Dec 31, 2025 53.83 Mn
Sep 30, 2025 53.83 Mn
Jun 30, 2025 53.83 Mn
Mar 31, 2025 53.83 Mn
Dec 31, 2024 53.77 Mn
Sep 30, 2024 53.76 Mn
Jun 30, 2024 53.74 Mn
Mar 31, 2024 53.71 Mn
Dec 31, 2023 53.22 Mn
Sep 30, 2023 53.06 Mn
Jun 30, 2023 53.12 Mn
Mar 31, 2023 52.50 Mn
Dec 31, 2022 47.37 Mn
Sep 30, 2022 46.99 Mn
Jun 30, 2022 46.76 Mn
Mar 31, 2022 46.70 Mn
Dec 31, 2021 44.23 Mn
Sep 30, 2021 45.63 Mn
Jun 30, 2021 42.30 Mn